Archive for the 'Uncategorized' Category
PPD Establishes Network Of Sites For Conducting Phase I Trials In Patients
PPD, Inc. (Nasdaq: PPDI) announced it has established preferred provider relationships with a network of sites across North America for conducting Phase I trials in patients to meet growing client demand for these services. PPD has established relationships with Commonwealth Biomedical Research in Madisonville, Ky…
TenX Biopharma Reinitiates Enrollment In Pivotal Phase III, CTCL Trial
TenX Biopharma, Inc. announced that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients. The trial enrollment was suspended in October 2008 while Genmab (CO:GEN) was seeking a out-license agreement to further develop the compound…
To Reach, Perchance To Kill The Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That ‘Sea Of Troubles’
Epeius Biotechnologies Corporation, a leader in the emerging field of targeted genetic medicine, reports the publication of a landmark paper in clinical oncology. Following up on its advanced U.S…
ThromboGenics Presents Positive Pooled Results From The MIVI-TRUST Phase III Program
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France…
Road-Map Agreed For Confirmatory Trials Of Promising Microbicide
Two further clinical trials are planned to confirm a vaginal gel which has shown potential in reducing the risk of HIV. The results of the first trial of the gel, which were announced in July at the XVIII International AIDS Conference in Vienna, must be confirmed before the product can be made available for general use…
Gynecologic Cancer Patients Should Consider Clinical Trials
For the estimated 83,000 women who will be diagnosed with a gynecologic cancer in 2010, participation in clinical trials offers an opportunity both to ensure that future patients benefit from the most up-to-date treatments and increased survival rates and to potentially improve the health of current patients…
Successful Completion Of First Clinical Trials On Potent New Hepatitis C Drug
The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed…
Depression Significantly Improved By Non-Invasive Therapy
Major depression is a common and disabling brain condition marked not only by the presence of depressed mood but also by its effects on sleep, energy, decision-making, memory and thoughts of death or of suicide. Major depression affects 15 million adults in the U.S…
Merck’s Cladribine Tablets For Multiple Sclerosis Approved In Australia
Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tablets will be registered in Australia under the trade name Movectro®…
HeartWare Receives Second Patient Allotment Under Continued Access Protocol For Pivotal U.S. Bridge-To-Transplant Clinical Trial
HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S…
